Biomerica, Inc. (BMRA)

Biomerica Income Statement

Financials in millions USD. Fiscal year is June - May.

Year Ending	TTM	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019
Revenue	5.41	5.34	18.87	7.2	6.69	5.2
Revenue Growth (YoY)	-43.29%	-71.71%	162.13%	7.57%	28.69%	-6.53%
Cost of Revenue	4.79	4.89	15.89	6.83	4.95	3.91
Gross Profit	0.62	0.45	2.98	0.37	1.74	1.29
Selling, General & Admin	5.7	6.09	5.7	5.67	2.55	2.03
Research & Development	1.6	1.58	1.81	2.19	1.93	1.68
Operating Expenses	7.29	7.67	7.51	7.87	4.48	3.7
Operating Income	-6.68	-7.22	-4.53	-7.5	-2.74	-2.41
Interest Expense / Income	0	0	0	0	0	0
Other Expense / Income	-0.37	-0.13	-0.03	-0.07	-0.07	-0.04
Pretax Income	-6.3	-7.09	-4.51	-7.43	-2.67	-2.37
Income Tax	0.05	0.05	0.02	0.01	0.01	0.02
Net Income	-6.35	-7.14	-4.53	-7.45	-2.68	-2.39
Shares Outstanding (Basic)	17	14	13	12	10	9
Shares Outstanding (Diluted)	17	14	13	12	10	9
Shares Change	24.78%	11.69%	6.24%	17.34%	10.35%	7.50%
EPS (Basic)	-0.37	-0.50	-0.36	-0.62	-0.26	-0.26
EPS (Diluted)	-0.37	-0.50	-0.36	-0.62	-0.26	-0.26
Free Cash Flow	-5.31	-5.54	-0.54	-5.39	-4.33	-2.35
Free Cash Flow Per Share	-0.32	-0.39	-0.04	-0.45	-0.43	-0.26
Gross Margin	11.41%	8.35%	15.78%	5.09%	25.97%	24.84%
Operating Margin	-123.51%	-135.29%	-24.03%	-104.18%	-40.95%	-46.39%
Profit Margin	-117.46%	-133.73%	-24.01%	-103.43%	-40.00%	-46.01%
Free Cash Flow Margin	-98.18%	-103.73%	-2.84%	-74.84%	-64.71%	-45.09%
EBITDA	-5.94	-6.74	-3.91	-7.06	-2.27	-2.21
EBITDA Margin	-109.91%	-126.20%	-20.73%	-98.03%	-33.93%	-42.42%
Depreciation & Amortization	0.36	0.35	0.6	0.38	0.4	0.16
EBIT	-6.3	-7.09	-4.51	-7.43	-2.67	-2.37
EBIT Margin	-116.58%	-132.78%	-23.88%	-103.25%	-39.89%	-45.55%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).